A Business Case for QualityByStephen A. Somers, PhD,Melanie Bella, MBA. Author reply by David A. Dorr, MD.May 1st 2007
Current and Future Directions in Medi-Cal Chronic Disease Care Management: A View From the TopByL. Elizabeth Goldman, MD, MCR,Margaret Handley, PhD,Thomas G. Rundall, PhD,Dean Schillinger, MDMay 1st 2007
Willingness to Attend Group Visits for Hypertension TreatmentByLumie Kawasaki, MD, MBA,Paul Muntner, PhD,Amanda D. Hyre, MPH,Kashley Hampton, BA,Karen B. DeSalvo, MDMay 1st 2007
The Response of Physician Groups to P4P IncentivesByAteev Mehrotra, MD, MPH,Steven D. Pearson, MD, MSc,Kathryn L. Coltin, MPH,Ken P. Kleinman, PhD,Janice A. Singer, MPH,Barbra Rabson, MPH,Eric C. Schneider, MD, MScMay 1st 2007
Physician-level P4P—DOA? Can Quality-based Payment Be Resuscitated?ByLaurence F. McMahon Jr, MD, MPH,Timothy P. Hofer, MD,Rodney A. Hayward, MDMay 1st 2007
Impact of Hospital Formularies on Fluoroquinolone Prescribing in Emergency DepartmentsBySherrie L. Aspinall, PharmD, MSc,Joshua P. Metlay, MD, PhD,Judith H. Maselli, MSPH,Ralph Gonzales, MD, MSPHMay 1st 2007
